Evidence map›Paper›PMID 36978747›Full record

ReviewBioengineering (Basel, Switzerland)2023

Host Immune Regulation in Implant-Associated Infection (IAI): What Does the Current Evidence Provide Us to Prevent or Treat IAI?

Zulipikaer Maimaiti, Zhuo Li, Chi Xu, Jun Fu, Li-Bo Hao, Ji-Ying Chen, Wei Chai

Open access · goldFull text readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Surface Oxide Film and Antibacterial Activity of Zirconium-Based Bulk Metallic Glasses.Langmuir : the ACS journal of surfaces and colloids · 2026
    Article
  6. Review
  7. Review
  8. Piezoelectric Biomaterial with Advanced Design for Tissue Infection Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Development of aAntibiotics (Basel, Switzerland) · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zulipikaer MaimaitiDepartment of Orthopaedics, The Fourth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China.ORCID 0000-0002-8684-5885
Zhuo LiDepartment of Orthopaedics, The First Medical Centre, Chinese PLA General Hospital, Beijing 100853, China.ORCID 0000-0002-9296-2738
Chi XuDepartment of Orthopaedics, The Fourth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China.ORCID 0000-0003-4211-0657
Jun FuDepartment of Orthopaedics, The Fourth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China.
Li-Bo HaoDepartment of Orthopaedics, The Fourth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China.
Ji-Ying ChenDepartment of Orthopaedics, The Fourth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China.
Wei ChaiDepartment of Orthopaedics, The Fourth Medical Centre, Chinese PLA General Hospital, Beijing 100048, China.
Chinese PLA General Hospital · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of orthopedic implants for bone fixation and joint arthroplasty has been steadily increasing over the past few years. However, implant-associated infection (IAI), a major complication in orthopedic surgery, impacts the quality of life and causes a substantial economic burden on patients and societies. While research and study on IAI have received increasing attention in recent years, the failure rate of IAI has still not decreased significantly. This is related to microbial biofilms and their inherent antibiotic resistance, as well as the various mechanisms by which bacteria evade host immunity, resulting in difficulties in diagnosing and treating IAIs. Hence, a better understanding of the complex interactions between biofilms, implants, and host immunity is necessary to develop new strategies for preventing and controlling these infections. This review first discusses the challenges in diagnosing and treating IAI, followed by an extensive review of the direct effects of orthopedic implants, host immune function, pathogenic bacteria, and biofilms. Finally, several promising preventive or therapeutic alternatives are presented, with the hope of mitigating or eliminating the threat of antibiotic resistance and refractory biofilms in IAI.

Indexed as

antibacterialbiofilmhostimmune modulationimplant-associated infectionnanomaterial

Identifiers

PMID36978747
PMCPMC10044746
OpenAlexW4324153607

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read17
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.